The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs
Abstract
Fueled by the global surge in aging, atherosclerotic cardiovascular disease reached pandemic dimensions putting affected individuals at enhanced risk of myocardial infarction, stroke, and premature death. Atherosclerosis is a systemic disease driven by a wide spectrum of factors, including cholesterol, pressure, and disturbed flow. Although all arterial beds encounter a similar atherogenic milieu, the development of atheromatous lesions occurs discontinuously across the vascular system. Indeed, the internal mammary artery possesses unique biological properties that confer protection to intimal growth and atherosclerotic plaque formation, thus making it a conduit of choice for coronary artery bypass grafting. Its endothelium abundantly expresses nitric oxide synthase and shows accentuated nitric oxide release, while its vascular smooth muscle cells exhibit reduced tissue factor expression, high tPA (tissue-type plasminogen activator) production and blunted migration and proliferation, which may collectively mitigate intimal thickening and ultimately the evolution of atheromatous plaques. We aim here to provide insights into the anatomy, physiology, cellular, and molecular aspects of the internal mammary artery thereby elucidating its remarkable resistance to atherogenesis. We propose a change in perspective from risk to resilience to decipher mechanisms of atheroresistance and eventually identification of novel therapeutic targets presently not addressed by currently available remedies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Aggressive LDL-C lowering reduces coronary plaque burden and reduces the risk of ASCVD-related events.
“aggressive LDL-C lowering reduces coronary plaque burden and reduces the risk of ASCVD-related events.6–8”
From Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation (2025) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Cardiovascular and renal outcomes with empagliflozin in heart failure
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., Januzzi, J., Verma, S., Tsutsui, H., Brueckmann, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022190 · Cited by 5,206
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801174 · Cited by 3,634
Efficacy and safety of low-dose colchicine after myocardial infarction
Tardif, J.-C., Kouz, S., Waters, D. D., Bertrand, O. F., Diaz, R., Maggioni, A. P., Pinto, F. J., Ibrahim, R., Gamra, H., Kiwan, G. S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1912388 · Cited by 3,159
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Self-citationColchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Flagged first, then by citations
Research works printed but not linked: 136
- 10.1016/j.jacc.2007.02.059 · DOI · Paper page
- 10.1056/NEJM199601253340411 · DOI
- 10.1016/0003-4975(89)90027-1 · DOI
- 10.1016/j.jacc.2004.08.064 · DOI
- 10.1016/0735-1097(96)00206-9 · DOI
- 10.1038/s41572-019-0106-z · DOI · Paper page
- 10.7326/0003-4819-55-1-33 · DOI · Paper page
- 10.1001/jama.290.7.898 · DOI · Paper page
- The Surgeon General’s 1990 Report on The Health Benefits of Smoking Cessation. Executive Summary. MMWR Recomm reports Morb Mortal Wkly report Recomm reports. 1990;39(RR-12):i-xv, 1–12.
- 10.1001/jama.1995.03530020049031 · DOI · Paper page
- 10.1016/0140-6736(90)90878-9 · DOI · Paper page
- 10.1016/S0140-6736(09)61717-7 · DOI · Paper page
- 10.1161/JAHA.119.012638 · DOI
- 10.1016/j.jacc.2012.10.027 · DOI
- 10.1056/NEJMoa1707914 · DOI · Paper page
- 10.1016/j.jacc.2019.06.007 · DOI
- 10.1016/S0140-6736(94)90566-5 · DOI
- 10.1016/s0140-6736(00)03307-9 · DOI · Paper page
- 10.1016/S2213-8587(17)30412-6 · DOI · Paper page
- 10.1161/JAHA.119.014908 · DOI · Paper page
- 10.1016/j.jacc.2017.09.028 · DOI
- 10.1016/S0140-6736(17)32814-3 · DOI
- 10.1111/eci.13424 · DOI
- 10.1016/s0003-4975(10)63917-3 · DOI
- 10.1161/01.cir.100.suppl_2.ii-139 · DOI
- 10.1111/j.1540-8191.2007.00431.x · DOI
- 10.1016/0021-9150(87)90234-6 · DOI
- Stary, HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis. 1989;9(suppl 1):I19–32.
- Movat, HZ, More, RH, Haust, MD. The diffuse intimal thickening of the human aorta with aging. Am J Pathol. 1958;34:1023–1031.
- 10.1161/01.res.53.4.502 · DOI
- 10.1161/01.cir.85.1.391 · DOI
- 10.1016/0002-8703(83)90478-7 · DOI
- 10.1016/j.carpath.2007.05.007 · DOI
- 10.1161/01.cir.0000013836.85741.17 · DOI · Paper page
- 10.1073/pnas.92.24.11190 · DOI
- 10.1016/0002-8703(89)90068-9 · DOI
- 10.1161/01.ATV.0000105054.43931.f0 · DOI
- 10.1016/s0003-4975(96)01393-8 · DOI
- 10.1016/s0022-5223(03)01226-1 · DOI
- 10.3109/14017439009101814 · DOI
- 10.14670/HH-28.1299 · DOI
- 10.1016/S0022-5223(19)33998-4 · DOI
- 10.1016/S1010-7940(01)00919-8 · DOI
- 10.1016/S0022-5223(95)70398-5 · DOI
- 10.1093/ejcts/ezt430 · DOI
- 10.1007/BF02552775 · DOI
- 10.1001/jama.276.18.1517 · DOI
- 10.1093/eurheartj/ehy394 · DOI · Paper page
- 10.1056/NEJM198601023140101 · DOI
- 10.1016/S0022-5223(94)70320-5 · DOI
- 10.1056/NEJM199601253340402 · DOI
- 10.1161/01.cir.77.4.815 · DOI
- 10.1097/HCO.0b013e32834b9f87 · DOI
- 10.1016/j.jacc.2012.03.037 · DOI
- 10.3978/j.issn.2225-319X.2013.07.06 · DOI
- 10.1016/0735-1097(88)90094-0 · DOI
- 10.1016/s0735-1097(00)00973-6 · DOI
- 10.1016/j.jtcvs.2013.07.029 · DOI
- 10.1016/0735-1097(93)90429-5 · DOI · Paper page
- 10.1016/j.amjcard.2016.09.011 · DOI
- 10.1016/s0003-4975(98)00757-7 · DOI
- 10.1016/j.athoracsur.2012.04.035 · DOI
- 10.1161/JAHA.116.003568 · DOI
- 10.1136/heartjnl-2016-310864 · DOI
- 10.1056/NEJMoa1808783 · DOI
- 10.1093/ejcts/ezx358 · DOI
- Uflacker, A, Guimaraes, M. Uflacker’s Atlas of Vascular Anatomy: An Angiographic Approach. 3rd Ed. Lippincott Williams & Wilkins (LWW); 2020.
- 10.1016/s0003-4975(02)03584-1 · DOI
- 10.4103/0971-9784.119161 · DOI
- 10.1007/s12471-016-0919-2 · DOI
- 10.1016/0003-4975(93)90483-x · DOI
- 10.1016/s0008-6363(97)00056-4 · DOI
- 10.1016/S0022-5223(19)36947-8 · DOI
- 10.1002/ca.980070406 · DOI
- 10.1016/0021-9150(90)90169-J · DOI
- 10.1016/j.cardiores.2007.06.023 · DOI
- 10.1161/CIRCULATIONAHA.113.007189 · DOI
- 10.1016/j.jtcvs.2004.08.014 · DOI
- 10.1016/j.jvs.2004.06.032 · DOI
- 10.1074/mcp.M500088-MCP200 · DOI
- 10.1371/journal.pone.0054765 · DOI
- 10.1016/j.exer.2003.12.006 · DOI
- 10.1161/01.ATV.0000059303.94760.5C · DOI
- 10.1093/hmg/ddr574 · DOI
- 10.1056/NEJM198808253190802 · DOI
- 10.1161/CIRCULATIONAHA.105.582890 · DOI
- 10.1161/01.res.68.1.52 · DOI
- 10.1161/01.cir.97.25.2494 · DOI
- 10.1038/s41586-019-1140-4 · DOI
- 10.1161/01.cir.95.7.1870 · DOI
- 10.1016/0140-6736(92)93287-w · DOI
- 10.1161/01.cir.97.2.181 · DOI
- 10.1016/j.cardiores.2006.06.022 · DOI
- 10.1161/CIRCRESAHA.115.306361 · DOI · Paper page
- 10.1038/s41591-019-0512-5 · DOI
- 10.1038/s41569-019-0227-9 · DOI · Paper page
- 10.1172/jci.insight.95890 · DOI · Paper page
- 10.1093/cvr/cvs126 · DOI · Paper page
- 10.1038/362801a0 · DOI
- 10.1172/JCI115613 · DOI
- 10.1126/science.180.4093.1332 · DOI
- 10.1160/TH04-02-0122 · DOI
- 10.1161/CIRCULATIONAHA.105.567297 · DOI · Paper page
- 10.1161/ATVBAHA.107.155333 · DOI
- 10.1148/rg.254045151 · DOI
- 10.1002/j.1932-8737.1997.tb00006.x · DOI
- 10.1161/01.cir.0000131515.03336.f8 · DOI · Paper page
- 10.1161/CIRCRESAHA.116.309326 · DOI · Paper page
- 10.1016/j.athoracsur.2011.04.063 · DOI
- 10.1172/JCI114081 · DOI
- 10.1172/JCI118014 · DOI
- 10.1093/eurheartj/ehr304 · DOI · Paper page
- 10.1161/ATVBAHA.107.154658 · DOI
- 10.1016/0140-6736(91)91571-b · DOI
- 10.1093/eurheartj/ehv587 · DOI
- 10.1152/ajpheart.00230.2009 · DOI
- 10.1111/bcpt.13426 · DOI
- 10.1161/hh2101.098443 · DOI
- 10.1093/eurheartj/ehz551 · DOI
- 10.1161/ATVBAHA.114.303424 · DOI
- 10.1038/s41569-019-0239-5 · DOI
- 10.1093/cvr/cvaa085 · DOI
- 10.1161/01.atv.19.10.2298 · DOI
- 10.1016/S0022-5223(97)70406-9 · DOI
- 10.1016/s0167-5273(98)00188-0 · DOI
- 10.1016/s1010-7940(98)00023-2 · DOI
- 10.1016/0003-4975(93)91011-b · DOI
- 10.1161/CIRCULATIONAHA.110.979542 · DOI
- 10.1016/0735-1097(94)00448-Y · DOI
- 10.1161/CIRCINTERVENTIONS.113.000200 · DOI
- Kitamura, S, Seki, T, Kawachi, K, Morita, R, Kawata, T, Mizuguchi, K, Kobayashi, S, Fukutomi, M, Nishii, T, Kobayashi, H. Excellent patency and growth potential of internal mammary artery grafts in pediatric coronary artery bypass surgery. New evidence for a “live” conduit. Circulation. 1988;78(3 Pt 2):I129–I139.
- 10.1016/s0828-282x(09)70486-6 · DOI
- 10.1016/j.athoracsur.2005.05.005 · DOI
- 10.1007/s00395-007-0650-7 · DOI
- 10.1161/01.CIR.103.8.1164 · DOI
- 10.1016/s0003-4975(03)01022-1 · DOI
Cited by
Sorted by citations
Velagapudi, S., Miranda, M. X., Adla, P., Kraler, S., Mohammed, S. A., Baki, S., Robert, J., Rohrer, L., Lee, H., Jang, H.-D., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf087 · Cited by 4
Self-citation
Metadata
- Authors
- Kraler, S., Libby, P., Evans, P. C., Akhmedov, A., Schmiady, M. O., Reinehr, M., Camici, G. G., & Lüscher, T. F.
- Affiliations
- Center for Molecular Cardiology, University of Zürich, Switzerland (S.K., A.A., G.G.C., T.F.L.).
- Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (P.L.).
- Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, United Kingdom (P.C.E.).
- Clinic for Cardiac Surgery (M.O.S.), University Hospital Zurich, Switzerland.
- University Heart Centre, Institute of Pathology and Molecular Pathology (M.R.), University Hospital Zurich, Switzerland.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2021-08
- Volume
- 41
- Issue
- 8
- Pages
- 2237-2251
- ISSN
- 1079-5642
- 1524-4636
- PMC
- PMC8299999
- Cited by
- 65
- References
- 11
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review